HealthcarePharmaceuticals & BiotechnologyPharmaceuticals

Kilitch Drugs India Ltd

Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 27 filings·Updated 18 Aug 2026
Showing 10 of 27 filings.
18 Aug 20262 filings
Company UpdateMonitoring Agency Report

Monitoring Agency finds no deviation in Kilitch Drugs' rights proceeds; capex and GCP utilisation ongoing

Issue Overview and Utilisation

  • Type: Rights issue of equity shares; objects: capex for Greenfield Pen project and GCP.
  • Total issue size: rights issue; no undersubscription or revision reported.
  • Main objective: capex for Greenfield Pen project; General Corporate Purposes.
  • Utilisation as per offer document: no material deviation.
  • Deviations/changes: capex payments delayed pending final inspection.
  • Capex funding: partial utilisation; 1.12 crore utilised in Q1 FY27; balance ongoing.
  • GCP funds: unutilised at end of Q4 FY26; later utilised in FY27 for capex payments.
  • Governance: CA certificate dated 13 Aug 2026; MA reports no deviation.
  • Material events: no events affecting viability reported.
  • Approvals: explicit approvals not detailed; monitoring indicates no material deviation.
  • GCP board approval: not explicitly reported.
Filed 23:17View Source
Company UpdateNewspaper Publication

We are submitting herewith the publication of extract of the financial results for the quarter ended 30th June 2026

Filed 22:52View Source
13 Aug 20261 filing
Board MeetingOutcome of Board Meeting

Kilitch Drugs (India) Ltd approves Q1 2026 unaudited standalone and consolidated results

Financial results approved

  • Standalone unaudited results for quarter ended 30 June 2026 approved
  • Consolidated unaudited results for quarter ended 30 June 2026 approved
  • Limited Review Report by auditors submitted with results

Audit and compliance

  • Independent auditor's review concluded no material misstatement
Filed 21:04View Source
10 Aug 20261 filing
Board Meeting

Kilitch Drugs India Ltd board meeting filing lacks date, time, and venue details

  • Meeting details (date, time, venue) not disclosed in this chunk.
Filed 10:31View Source
8 Jul 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Dematerialisation requests processed; confirmations issued to depositories; securities listed on exchanges.

Dematerialisation status

  • Dematerialisation requests processed; confirmations issued to depositories; securities listed on exchanges.
  • Physical certificates for dematerialisation mutilated and cancelled after verification; depository's name substituted as registered owner.
Filed 17:49View Source
7 May 20261 filing
Board Meeting

Kilitch Drugs India Ltd - 524500 - Board Meeting Intimation for Considering And Approval Of The Audited Financial Results For The Quarter And Year Ended 31St March 2026

Meeting Details

  • Board meeting on Friday, 15 May 2026.
  • Time and location were not disclosed.

Key Agenda Items

  • Approve audited standalone financial results for the quarter and year ended 31 March 2026.
  • Approve audited consolidated financial results for the quarter and year ended 31 March 2026.

Other Notes

  • Trading window closed from 1 April 2026.
  • Trading window reopens 48 hours after results are disclosed.
Filed 11:51View Source
14 Apr 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

We are hereby submitting certificate under regulation 74(5) of SEBI (DP) Regulations received from MUFG Intime India Private Limited, RTA of the Company

Filed 13:38View Source
25 Mar 20262 filings
OthersOutcome without intimation

Board approved the allotment of bonus equity shares in the ratio of 1:1

Filed 12:20View Source
Insider Trading / SASTClosure of Trading Window

Closure of Trading Window

Filed 09:50View Source
17 Mar 20261 filing
Corp. ActionRecord Date

Kilitch Drugs India Ltd - 524500 - Intimation Of Record Date Pursuant To Regulation 42 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Bonus Issue Record Date

  • Record date fixed as 24 March 2026 for bonus equity shares entitlement
  • Bonus issue ratio is 1:1, one bonus share for each equity share held
  • Bonus shares are equity shares of Rs. 10 each
  • Deemed date of allotment of bonus shares is 25 March 2026
  • Shareholders registered by closing hours of 24 March 2026 are eligible
Filed 15:20View Source
Showing 10 of 27 filings